ArticleNeoplasia (New York, N.Y.)2014

Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenografts.

Aarif Ahsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.